Filter
471
Text search:
adverse
drug
event
Featured
Recommendations
65
New Publications
103
Language
Document type
No document type
255
Guidelines
86
Studies & Reports
66
Manuals
29
Strategic & Response Plan
15
Fact sheets
8
Training Material
6
Situation Updates
3
App
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
28
Western and Central Europe
23
Global
14
South Africa
13
Latin America and the Carribbean
11
Ethiopia
10
Eastern Europe
10
Nigeria
9
Uganda
9
Kenya
9
Africa
9
Ghana
8
Syria
5
Bangladesh
5
Philippines
4
Nepal
4
Tanzania
4
Rwanda
4
South–East Asia Region
4
Liberia
3
USA
3
Zimbabwe
3
Cambodia
3
Malawi
3
Namibia
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Sierra Leone
2
Lesotho
2
West and Central Africa
2
Asia
2
Tajikistan
2
Congo, Democratic Republic of
1
Cameroon
1
South Sudan
1
Iraq
1
Zambia
1
China
1
Mozambique
1
Argentina
1
Eswatini/ Swaziland
1
North Macedonia
1
Ukraine
1
Botswana
1
East and Southern Africa
1
Western Pacific Region
1
Bhutan
1
Timor Leste/ East Timor
1
Russia
1
Kyrgyzstan
1
Kazakhstan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
141
Clinical Guidelines
74
Public Health
27
Women & Child Health
25
Key Resources
15
Pharmacy & Technologies
12
Capacity Building
8
Toolboxes
TB
56
Mental Health
50
HIV
44
COVID-19
31
Pharmacy
23
AMR
17
Caregiver
16
NTDs
16
NCDs
10
Ebola & Marburg
9
Rapid Response
9
Planetary Health
9
Conflict
7
Specific Hazards
7
Malaria
6
Natural Hazards
5
Refugee
5
2.0 Rapid Response
5
Disability
4
Polio
4
Global Health Education
4
Cholera
2
Zika
1
Social Ethics
1
Para a elaboração deste documento, o Grupo de Farmacovigilância da Rede Pan-americana para a Harmonização Farmacêutica (PARF) baseou-se na perspectiva da OPAS/OMS, a qual considera a Farmacovigilância como componente essencial dos programas de saúde pública (3). Trabalhou-se com a intençã
...
Joining efforts to control two trelated global epidemics.
The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.
Accessed November 2017
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Patient Safety tutorial 325
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...